Valuing health-related quality of life. A review of health state valuation techniques.
about
The impact of illness in patients with moderate to severe gastro-esophageal reflux diseaseDeveloping an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making.Analyzing Personal Happiness from Global Survey and Weather Data: A Geospatial ApproachHealth and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling studyExclusion Criteria in National Health State Valuation Studies: A Systematic Review.The disutility of restenosis--the impact of repeat percutaneous coronary intervention on quality of life.Obstetrical outcome valuations by patients, professionals, and laypersons: differences within and between groups using three valuation methods.The relationship between change in subjective outcome and change in disease: a potential paradoxHealth-related quality-of-life measurement in hypertension. A review of randomised controlled drug trials.Health-related quality of life changes associated with buprenorphine treatment for opioid dependence.Estimation of a preference-based carer experience scale.On the societal value of health care: what do we know about the person trade-off technique?Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol.Glaucoma patients' assessment of their visual function and quality of lifePatients' values and preferences of the expected efficacy of hip arthroscopy for osteoarthritis: a protocol for a multinational structured interview-based study combined with a randomised survey on the optimal amount of information to elicit prefereHow is the most severe health state being valued by the general population?Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients.A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD)Measuring preferences for cost-utility analysis: how choice of method may influence decision-makingLongitudinal association of preference-weighted health-related quality of life measures and substance use disorder outcomesA generalized measurement model to quantify health: the multi-attribute preference response modelQuantification of health by scaling similarity judgments.The validity of the Child Health Utility instrument (CHU9D) as a routine outcome measure for use in child and adolescent mental health services.Are Asians comfortable with discussing death in health valuation studies? A study in multi-ethnic SingaporeQuality of life implications of bisphosphonate-associated osteonecrosis of the jaw.Valuation of health states in the US study to establish disability weights: lessons from the literature.Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trialDo individuals with and without depression value depression differently? And if so, why?Evaluation of the cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom.Comparing Utility Scores in Common Spinal Radiculopathies: Results of a Prospective Valuation Study.Visual analogue scales: scale recalibration by patients with dementia and their proxies.Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities.One-to-one versus group setting for conducting computer-assisted TTO studies: findings from pilot studies in England and the Netherlands.Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer.Eliciting Patient Risk Willingness in Clinical Consultations as a Means of Improving Decision-Making of Aortic Valve ReplacementHow bad is depression? Preference score estimates from depressed patients and the general population.Valuation of transfusion-free living in MDS: results of health utility interviews with patients.Health outcomes in economic evaluation: who should value health?Methods and issues associated with the use of quality-adjusted life-years.Korean guidelines for pharmacoeconomic evaluation (second and updated version) : consensus and compromise.
P2860
Q24810618-DB7BC06E-CE26-4D1E-B541-DA03ACC4BF35Q27321275-BD0D81CD-68BD-42B4-BCE2-77E38DA29575Q30000263-F65D66DB-86F8-4C48-BE8C-6592B43A808EQ30210097-CC167D46-D939-4FE9-A400-F8D251E57130Q30252110-9D68B114-FB67-491A-AB4C-5BF3B12B60BFQ33994074-09511036-DAA9-41E3-A901-E764B0FAA63AQ34073146-67C169E1-1F76-4603-93F5-6617D67EA7DDQ34073425-6EEDC45D-18F9-46A9-A45C-FC96925994FCQ34126819-1911184F-33AF-4595-981E-A9D277F1F637Q34129263-2557E790-6A95-4748-B418-31BC8A9516C6Q34141946-51D1B11F-8454-4FB6-A686-86B05170C2CFQ34208567-F29D7A21-3195-4771-A273-64BBDF5C0B18Q34286102-EDB90652-01A6-48DC-BCB3-33413A5BAE5FQ34331239-2B751A01-2756-41DE-93CF-C4BABAFD4CC4Q34364998-727CD493-EF65-492B-ACAA-E9247C8C38EBQ34416777-2F8E9EEC-6898-4BBF-AC93-EDC4E94961F8Q34423176-A94B7D24-A019-433A-AA7A-B225D589D284Q34473088-715B2E7C-945C-45A3-95CD-03BC173232E8Q34614168-EAED16F8-29B7-49B0-A183-5C0743E67C6AQ34789105-179F1B00-4827-4316-BD28-4C5F13AE0CBFQ35053174-D31A02CF-D24B-4F81-972F-15E3F8A46BF6Q35106658-6EB4AC25-254A-4571-AEB0-EE28991F56C7Q35122676-A3E9DB43-1F59-4ECC-8C2E-3F220802E1C4Q35221240-CF686021-BFCB-4A14-BBA7-E4E5E8729046Q35584343-4B954DAF-9B01-4F6C-A551-184C6B40E7E4Q35835421-15C57D92-2A44-4592-AEEA-DF97C32034B9Q36091640-A745ECF5-E418-4865-9A3F-807643F1A303Q36118879-1C7FBBD7-D699-4DDA-9D5C-6AACE60FA4C3Q36468104-083EF0C0-75BE-4559-B616-042C0A0C042AQ36813425-92A51E02-1350-4325-812C-B00121DBCA78Q36878211-13C8582B-1EE2-4FCD-9A6C-EEF05F322724Q36935821-E54EB2BD-205F-44B6-A8B6-804D5C2E39FEQ37057573-4C3E436A-AE85-4C0A-B70E-F4038824F29CQ37080811-705D8CF6-0704-4D0A-B6B9-02B1FC6ABC70Q37090783-F6EBBBAD-D976-4036-BE65-095AC2796189Q37335748-188C292A-E78A-4642-8237-3AFFAD5F8503Q37351945-7090991B-0061-447C-8710-F29B00F00A99Q37834127-E2F73F5E-3FDF-446F-9FA7-4FC26E2A4D01Q37978909-5E5142FB-786F-40A1-BFA1-1BB668BF30B6Q38074370-75D7C3CA-E721-4425-86C3-04D759270E71
P2860
Valuing health-related quality of life. A review of health state valuation techniques.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Valuing health-related quality of life. A review of health state valuation techniques.
@ast
Valuing health-related quality of life. A review of health state valuation techniques.
@en
Valuing health-related quality of life. A review of health state valuation techniques.
@nl
type
label
Valuing health-related quality of life. A review of health state valuation techniques.
@ast
Valuing health-related quality of life. A review of health state valuation techniques.
@en
Valuing health-related quality of life. A review of health state valuation techniques.
@nl
prefLabel
Valuing health-related quality of life. A review of health state valuation techniques.
@ast
Valuing health-related quality of life. A review of health state valuation techniques.
@en
Valuing health-related quality of life. A review of health state valuation techniques.
@nl
P2093
P1433
P1476
Valuing health-related quality of life. A review of health state valuation techniques.
@en
P2093
P304
P356
10.2165/00019053-200017020-00004
P577
2000-02-01T00:00:00Z
P6179
1014691793